Archives

img-01

Asia Orthopedics Update

Asia has a population of over 4 billion people, and represents about 60% of the world's population. Annual economic growth rates in the Asian countries have been as high as 8 or 10% over the past decade, in comparison with some developed... Read More

img-01

Japan: New GLP Updates

In accordance with the new Pharmaceutical Affairs Law (PAL), which went into effect on April 1, 2005, the Ministry of Health, Labor, and Welfare (MHLW) issued an update on Good Laboratory Practice (GLP) in Notification 0331030. This notification clarifies that GLP is... Read More

img-01

Japan’s New GVP Updates

Japan’s new Pharmaceutical Affairs Law (PAL), effective as of April 1, 2005, outlines the new post-marketing safety measures, also known as Good Vigilance Practice (GVP). This regulation clarifies the responsibilities of distributors of medical devices, drugs, quasi-drugs, and cosmetic products. All Marketing... Read More

img-01

Japan: New GCP Updates on Written Informed Consent

Japan ‘s New Pharmaceutical Affairs Law, effective as of April 1, 2005, outlines new Good Clinical Practice (GCP) guidelines, including the specific requirements for informed consent and privacy statements. Previously, a verbal informed consent by the study participants was acceptable, but the... Read More